Last month, the Senate voted 50-46 to confirm Dr. Robert Califf as Commissioner of the Food and Drug Administration (FDA), putting an end to the year-old vacancy at this health agency. President Biden’s selection of Dr. Califf was rife with controversy from both Democratic and Republican senators, with five Democrats voting against and six Republicans voting for the nominee. Keep reading to learn more about the new commissioner, reasons for controversy around his nomination and his plan for the future of the FDA. Read More >>>

View PDF